188 related articles for article (PubMed ID: 38029612)
1. RhoGDI3 at the trans-Golgi network participates in NLRP3 inflammasome activation, VSMC phenotypic modulation, and neointima formation.
Sun J; Zhu Q; Yu X; Liang X; Guan H; Zhao H; Yao W
Atherosclerosis; 2023 Dec; 387():117391. PubMed ID: 38029612
[TBL] [Abstract][Full Text] [Related]
2. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.
Tang L; Dai F; Liu Y; Yu X; Huang C; Wang Y; Yao W
Pharmacol Res; 2018 Jul; 133():201-212. PubMed ID: 29791873
[TBL] [Abstract][Full Text] [Related]
3. Protective Role of Cytochrome C Oxidase 5A (COX5A) against Mitochondrial Disorder and Oxidative Stress in VSMC Phenotypic Modulation and Neointima Formation.
Guan H; Sun J; Liang X; Yao W
Curr Vasc Pharmacol; 2023; 21(2):128-142. PubMed ID: 36924093
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of p90RSK Ameliorates PDGF-BB-Mediated Phenotypic Change of Vascular Smooth Muscle Cell and Subsequent Hyperplasia of Neointima.
Hwang AR; Lee HJ; Kim S; Park SH; Woo CH
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175802
[TBL] [Abstract][Full Text] [Related]
5. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
6. Galangin inhibits neointima formation induced by vascular injury
Wu B; Xu C; Ding HS; Qiu L; Gao JX; Li M; Xiong Y; Xia H; Liu X
Food Funct; 2022 Nov; 13(23):12077-12092. PubMed ID: 36367287
[No Abstract] [Full Text] [Related]
7. Inhibition of vascular neointima hyperplasia by FGF21 associated with FGFR1/Syk/NLRP3 inflammasome pathway in diabetic mice.
Wei W; Li XX; Xu M
Atherosclerosis; 2019 Oct; 289():132-142. PubMed ID: 31513948
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
[TBL] [Abstract][Full Text] [Related]
9. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade.
Lu QB; Wan MY; Wang PY; Zhang CX; Xu DY; Liao X; Sun HJ
Redox Biol; 2018 Apr; 14():656-668. PubMed ID: 29175753
[TBL] [Abstract][Full Text] [Related]
10. TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation.
Wu LP; Gong ZF; Wang H; Zhou ZS; Zhang MM; Liu C; Ren HM; Yang J; Han Y; Zeng CY
Acta Pharmacol Sin; 2020 Jan; 41(1):34-46. PubMed ID: 31515530
[TBL] [Abstract][Full Text] [Related]
11. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived growth factor suppresses VSMC dedifferentiation and attenuates postinjury neointimal formation in rats by activating S1PR2 and its downstream signaling.
Yang S; Li HW; Tian JY; Wang ZK; Chen Y; Zhan TT; Ma CY; Feng M; Cao SF; Zhao Y; Li X; Ren J; Liu Q; Jin LY; Wang ZQ; Jiang WY; Zhao YX; Zhang Y; Liu X
Acta Pharmacol Sin; 2024 Jan; 45(1):98-111. PubMed ID: 37726422
[TBL] [Abstract][Full Text] [Related]
13. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
[TBL] [Abstract][Full Text] [Related]
14. Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift.
Han JH; Park HS; Lee DH; Jo JH; Heo KS; Myung CS
Life Sci; 2021 Feb; 267():118978. PubMed ID: 33412209
[TBL] [Abstract][Full Text] [Related]
15. CFTR Suppresses Neointimal Formation Through Attenuating Proliferation and Migration of Aortic Smooth Muscle Cells.
Lu LY; Pan N; Huang ZH; Wang JS; Tang YB; Sun HS; Han H; Yang HY; Zhu JZ; Guan YY; Zhang B; Li DZ; Wang GL
J Cardiovasc Pharmacol; 2022 Jun; 79(6):914-924. PubMed ID: 35266910
[TBL] [Abstract][Full Text] [Related]
16. CircPCNX Promotes PDGF-BB-Induced Proliferation and Migration of Human Aortic Vascular Smooth Muscle Cells Through Regulating miR-1278/DNMT1 Axis.
Ma W; Wei D; Li X; Shan L; Fan H; Jin H; Song B; Zhang B
Cardiovasc Drugs Ther; 2023 Oct; 37(5):877-889. PubMed ID: 35670983
[TBL] [Abstract][Full Text] [Related]
17. miR-34c inhibits PDGF-BB-induced HAVSMCs phenotypic transformation and proliferation via PDGFR-β/SIRT1 pathway.
Wan WF; Zhang X; Huang CR; Chen LG; Yang XB; Bao KY; Peng TM
Mol Biol Rep; 2021 May; 48(5):4137-4151. PubMed ID: 34110576
[TBL] [Abstract][Full Text] [Related]
18. NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension.
Sun HJ; Ren XS; Xiong XQ; Chen YZ; Zhao MX; Wang JJ; Zhou YB; Han Y; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Death Dis; 2017 Oct; 8(10):e3074. PubMed ID: 28981106
[TBL] [Abstract][Full Text] [Related]
19. Apatinib attenuates phenotypic switching of arterial smooth muscle cells in vascular remodelling by targeting the PDGF Receptor-β.
Shao W; Li X; Peng J; Fan S; Liang M; Huang K
J Cell Mol Med; 2020 Sep; 24(17):10128-10139. PubMed ID: 32697395
[TBL] [Abstract][Full Text] [Related]
20. Effect of sinomenine on vascular smooth muscle cell dedifferentiation and neointima formation after vascular injury in mice.
Zhu L; Hao Y; Guan H; Cui C; Tian S; Yang D; Wang X; Zhang S; Wang L; Jiang H
Mol Cell Biochem; 2013 Jan; 373(1-2):53-62. PubMed ID: 23065380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
